Abstract

Gene therapy, a medical approach that involves the correction or replacement of defective and abnormal genes, plays an essential role in the treatment of complex and refractory diseases, such as hereditary diseases, cancer, and rheumatic immune diseases. Nucleic acids alone do not easily enter the target cells due to their easy degradation in vivo and the structure of the target cell membranes. The introduction of genes into biological cells is often dependent on gene delivery vectors, such as adenoviral vectors, which are commonly used in gene therapy. However, traditional viral vectors have strong immunogenicity while also presenting a potential infection risk. Recently, biomaterials have attracted attention for use as efficient gene delivery vehicles, because they can avoid the drawbacks associated with viral vectors. Biomaterials can improve the biological stability of nucleic acids and the efficiency of intracellular gene delivery. This review is focused on biomaterial-based delivery systems in gene therapy and disease treatment. Herein, we review the recent developments and modalities of gene therapy. Additionally, we discuss nucleic acid delivery strategies, with a focus on biomaterial-based gene delivery systems. Furthermore, the current applications of biomaterial-based gene therapy are summarized.

MeSH

Cells, Genes, Biocompatible Materials, Nucleic Acids, Therapeutics

Cited by

• Biomaterial-based gene therapy. MedComm (2020), 2023
• Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies. J Hematol Oncol, 2024
• Recent progress of iron-based nanomaterials in gene delivery and tumor gene therapy. J Nanobiotechnology, 2024
• Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications. Mater Today Bio, 2024
• Biomaterials for Drug Delivery and Human Applications. Materials (Basel), 2024
• Targeted spleen modulation: a novel strategy for next-generation disease immunotherapy. Theranostics, 2025
• Drug Delivery of Gelatin Nanoparticles as a Biodegradable Polymer for the Treatment of Infectious Diseases: Perspectives and Challenges. Polymers (Basel), 2023
• Emerging biomaterials and bio-nano interfaces in pulmonary hypertension therapy: transformative strategies for personalized treatment. Front Bioeng Biotechnol, 2025
• Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy. J Nanobiotechnology, 2024
• A Review on the Stability Challenges of Advanced Biologic Therapeutics. Pharmaceutics, 2025
• Developing hydrogels for gene therapy and tissue engineering. J Nanobiotechnology, 2024